Studies in a murine Csf2rb−/− model confirmed that allogeneic and autologous HSCT in combination with gene therapy can efficiently cure the PAP disease phenotype [57,58,59] (see also Table 1). Here, CSF2RB is linked to pulmonary alveolar proteinosis.